Literature DB >> 7714068

Endocrine therapy of prostate cancer: optimal form and timing.

F Labrie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7714068     DOI： 10.1210/jcem.80.4.7714068

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  3 in total

1.  Possibility of recovery of estrogen sensitivity following high-dose glucocorticoid therapy in a patient with hormone-refractory prostate cancer.

Authors:  Shinya Yamamoto; Jyunji Yonese; Satoru Kawakami; Tetsuro Tsukamoto; Yuhei Ohkubo; Manabu Tatokoro; Iwao Fukui
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

Review 2.  Human steroid biosynthesis for the oncologist.

Authors:  Mary Louise Auchus; Richard J Auchus
Journal:  J Investig Med       Date:  2012-02       Impact factor: 2.895

3.  Leuprorelin acetate long-lasting effects on GnRH receptors of prostate cancer cells: an atomic force microscopy study of agonist/receptor interaction.

Authors:  Gina Lama; Massimiliano Papi; Cristiana Angelucci; Giuseppe Maulucci; Gigliola Sica; Marco De Spirito
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.